Recro Pharma, Inc. Business Finance Contracts & Agreements

69 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
FIFTH AMENDMENT TO PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS
Escrow Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2023
Fourth Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated October 3, 2023, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited...
Escrow Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2023
Third Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated April 21, 2023, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited liability...
Escrow Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2023
Second Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated January 23, 2023, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited...
Escrow Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2023
First Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated November 22, 2022, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited...
Escrow Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2023
Form of Pre-Funded Warrant
Warrant Agreements
Recro Pharma, Inc.
Pharmaceuticals
NY
2023
Underwriting Agreement, dated as of August 24, 2023, by and between Societal CDMO, Inc. and Craig-Hallum Capital Group, LLC, as representative of the underwriters
Underwriting Agreements
Recro Pharma, Inc.
Pharmaceuticals
NY
2023
First Amendment to Subordinated Promissory Note
Note Agreements
Recro Pharma, Inc.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant in favor of IriSys, Inc
Warrant Agreements
Recro Pharma, Inc.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant in favor of Warberg WF XI LP (as assigned by OTA LLC)
Warrant Agreements
Recro Pharma, Inc.
Pharmaceuticals
PA
2023
Underwriting Agreement relating to the Preferred Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the...
Underwriting Agreements
Recro Pharma, Inc.
Pharmaceuticals
2022
Underwriting Agreement relating to the Common Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the...
Underwriting Agreements
Recro Pharma, Inc.
Pharmaceuticals
2022
Credit Agreement, dated as of December 12, 2022, by Societal CDMO, Inc. in favor of RBC Capital Markets, LLC
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
PA
2022
Seventh Amendment to Credit Agreement, dated as of December 9, 2022, by and among Societal CDMO, Inc., certain subsidiaries of Societal CDMO, Inc., named as guarantors therein,...
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
2022
Purchase and Sale Agreement, dated as of December 9, 2022, by and between Societal CDMO Gainesville, LLC and Tenet Equity Funding SPE Gainesville, LLC
Purchase Agreements
Recro Pharma, Inc.
Pharmaceuticals
2022
Purchase and Sale Agreement and Joint Escrow Instructions dated August 11, 2022, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited liability company and Weekley...
Escrow Agreements
Recro Pharma, Inc.
Pharmaceuticals
GA
2022
Sixth Amendment to Credit Agreement, dated as of August 13, 2021, by and among Recro Pharma, Inc., certain subsidiaries of Recro Pharma, Inc., named as guarantors therein, the...
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
2021
Form of Subordinated Promissory Note
Note Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2021
Unit Purchase Agreement, dated August 13, 2021, by and among Recro Pharma, Inc., IriSys, LLC, the Sellers (as defined therein), and IriSys, Inc. as the Sellers Representative
Purchase Agreements
Recro Pharma, Inc.
Pharmaceuticals
CA
2021
Form of Inducement Award Agreement for Restricted Stock Units
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
PA
2021
Form of Non-Qualified Stock Option Inducement Award Agreement
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
2021
Underwriting Agreement, dated as of May 12, 2021, by and between Recro Pharma, Inc. and William Blair & Company, L.L.C., as representative of the underwriters
Underwriting Agreements
Recro Pharma, Inc.
Pharmaceuticals
2021
Second Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated February 26, 2021
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
2021
Form of Award Agreement for Restricted Stock Units
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
PA
2021
Form of Non-Qualified Stock Option Award Agreement
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
2021
Stock Issuance Agreement, dated as of February 19, 2021 by and between Recro Pharma, Inc., Athyrium Opportunities II Acquisition LP and Athyrium Opportunities III Acquisition LP
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
NY
2021
Fifth Amendment to Credit Agreement and Investment Documents, dated as of February 19, 2021, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
2021
Fourth Amendment to Credit Agreement and Investment Documents, dated as of November 5, 2020, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
2020
First Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated August 7, 2020
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
2020
Note dated May 12, 2020, between Recro Pharma, Inc. and PNC Bank, National Association
Note Agreements
Recro Pharma, Inc.
Pharmaceuticals
2020
Partial Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and...
Assignment Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2019
Third Amendment to Credit Agreement and Release Agreement, dated as of October 22, 2019, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
2019
Agreement, dated March 25, 2019, by and among Recro Pharma, Inc., Engine Capital, L.P., Engine Jet Capital, L.P., Engine Investments, LLC, and Arnaud Ajdler
Investment Agreements
Recro Pharma, Inc.
Pharmaceuticals
DE
2019
Second Amendment to Credit Agreement and Investment Documents, dated February 28, 2019, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party...
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
PA
2019
Common Stock Purchase Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
IL
2019
Registration Rights Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC
Registration Rights Agreements
Recro Pharma, Inc.
Pharmaceuticals
IL
2019
First Amendment to Credit Agreement and Investment Documents, dated December 28, 2018, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party...
Credit Agreements
Recro Pharma, Inc.
Pharmaceuticals
PA
2019
Second Amendment to Purchase and Sale Agreement, dated December 20, 2018, by and between Recro Pharma, Inc., Recro Gainesville LLC, Alkermes Pharma Ireland Limited, Daravita...
Purchase Agreements
Recro Pharma, Inc.
Pharmaceuticals
2018
First Amendment to Warrant to Purchase Common Stock, dated December 20, 2018
Warrant Agreements
Recro Pharma, Inc.
Pharmaceuticals
2018
Common Stock Purchase Agreement, dated March 2, 2018, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC
Stock Agreements
Recro Pharma, Inc.
Pharmaceuticals
IL
2018